Survivin expression and serum levels in pancreatic cancer

BACKGROUND: Survivin, an inhibitor of apoptosis, is overexpressed in pancreatic ductal adenocarcinoma (PDAC). Its expression is known to be associated with poor clinical outcome. However, to our knowledge, there has been no study to characterize its usefulness as a serum marker for human pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, He, Qian, Dongmeng, Wang, Yaqiu, Meng, Lingsheng, Chen, Dong, Ji, Xiangyu, Feng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469100/
https://www.ncbi.nlm.nih.gov/pubmed/26016480
http://dx.doi.org/10.1186/s12957-015-0605-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469100/
https://www.ncbi.nlm.nih.gov/pubmed/26016480
http://dx.doi.org/10.1186/s12957-015-0605-7

Ejemplares similares